Insights

Strong Funding Backing Character Biosciences has secured over 110 million dollars in Series B funding, including significant investment from Sanofi Ventures, indicating strong investor confidence and financial stability that supports expansion and development of innovative therapies.

Strategic Partnerships The company's collaboration with major ophthalmology entities like Bausch + Lomb demonstrates an openness to strategic alliances, providing opportunities for joint ventures, licensing arrangements, and co-development initiatives in ophthalmic drug discovery.

Advanced Tech Platform Utilizing AI-driven genomics and multi-modal data integration, Character Biosciences offers a cutting-edge platform that can be valuable for pharmaceutical partners seeking to enhance their precision medicine pipelines and clinical trial efficiencies.

Market Focus on AMD With a dedicated focus on age-related macular degeneration and a deep phenotyping approach, there are opportunities to collaborate on targeted therapies, patient stratification, and personalized treatment strategies within the ophthalmology market.

Growth Potential Despite a relatively small team, the company’s rapidly progressing programs and recent funding rounds suggest high growth potential, making it an attractive partner for industries interested in innovative biotech solutions and early-stage drug development.

Similar companies to Character Biosciences

Character Biosciences Tech Stack

Character Biosciences uses 8 technology products and services including Google Ads, Cloudflare Web Optimizations, Google Cloud DNS, and more. Explore Character Biosciences's tech stack below.

  • Google Ads
    Advertising
  • Cloudflare Web Optimizations
    Analytics
  • Google Cloud DNS
    Domain Name Services
  • Google Workspace
    Email
  • Loadable-Components
    Javascript Libraries
  • TensorFlow
    Machine Learning
  • Microsoft Office
    Office Suites
  • Google Tag Manager
    Tag Management

Character Biosciences's Email Address Formats

Character Biosciences uses at least 1 format(s):
Character Biosciences Email FormatsExamplePercentage
First.Last@characterbio.comJohn.Doe@characterbio.com
80%
First@characterbio.comJohn@characterbio.com
18%
FLast@characterbio.comJDoe@characterbio.com
2%

Frequently Asked Questions

Where is Character Biosciences's headquarters located?

Minus sign iconPlus sign icon
Character Biosciences's main headquarters is located at San Francisco, California 94103 United States. The company has employees across 1 continents, including North America.

What is Character Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Character Biosciences's official website is characterbio.com and has social profiles on LinkedIn.

What is Character Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Character Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Character Biosciences have currently?

Minus sign iconPlus sign icon
As of June 2026, Character Biosciences has approximately 53 employees across 1 continents, including North America. Key team members include Chief Data And Analytics Officer: D. E.Vp Genetics And Data Sciences: M. V.Head Of People: J. W.. Explore Character Biosciences's employee directory with LeadIQ.

What industry does Character Biosciences belong to?

Minus sign iconPlus sign icon
Character Biosciences operates in the Biotechnology Research industry.

What technology does Character Biosciences use?

Minus sign iconPlus sign icon
Character Biosciences's tech stack includes Google AdsCloudflare Web OptimizationsGoogle Cloud DNSGoogle WorkspaceLoadable-ComponentsTensorFlowMicrosoft OfficeGoogle Tag Manager.

What is Character Biosciences's email format?

Minus sign iconPlus sign icon
Character Biosciences's email format typically follows the pattern of First.Last@characterbio.com. Find more Character Biosciences email formats with LeadIQ.

When was Character Biosciences founded?

Minus sign iconPlus sign icon
Character Biosciences was founded in 2019.

Character Biosciences

Biotechnology ResearchCalifornia, United States51-200 Employees

Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Our mission is to identify the genetic and molecular drivers of disease progression so we can develop targeted therapies for patients who urgently need them. 

We've built one of the most comprehensive resources in age-related eye diseases by partnering with over 150 ophthalmology clinics to integrate genetics with longitudinal clinical and imaging data. This deep phenotyping approach enables us to reclassify complex diseases like age-related macular degeneration (AMD) into genetically defined subtypes, unlocking novel therapeutic targets and optimizing patient selection for clinical trials.

Character Bio’s AI-powered platform combines genomics, multi-modal data, and machine learning to discover and develop therapies that are more precise and more effective. Our lead programs, CTX114 and CTX203, are advancing toward clinical trials and are designed to slow or prevent vision loss in AMD patients.

We are committed to delivering a new generation of precision medicines to treat and ultimately cure age-related blindness.

Section iconCompany Overview

Headquarters
San Francisco, California 94103 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $10M$25M

    Character Biosciences's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Character Biosciences's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.